VISANNE

This brand name is authorized in Austria, Canada, Ecuador, Finland, France, Hong Kong, Croatia, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug VISANNE contains one active pharmaceutical ingredient (API):

1 Dienogest UNII 46M3EV8HHE - DIENOGEST

Dienogest is a nortestosterone derivative with no androgenic but rather an antiandrogenic activity of approximately one third of that of cyproterone acetate. Dienogest binds to the progesterone receptor of the human uterus with only 10% of the relative affinity of progesterone. Read about Dienogest

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VISANNE Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DB08	Dienogest	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DB Pregnadien derivatives
Discover more medicines within G03DB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02374900
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29851-05-11
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 086924, 086935
Country: FR	Base de données publique des médicaments	Identifier(s): 63308748
Country: HK	Department of Health Drug Office	Identifier(s): 60781
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17658
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100226014
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64053001, W64053002, W64053003
Country: SG	Health Sciences Authority	Identifier(s): 13879P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 17463031
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546010035
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/21.8.2/0159